Peter Kim, M.D., is the Director of the Therapeutics Research Program at the Division of AIDS, National Institute of Allergy and Infectious Diseases. He currently oversees a broad portfolio of research grants and contracts involving diagnostics and therapeutics for HIV, tuberculosis, and other HIV related co-infections. His primary areas of expertise and interest include clinical TB and HIV drug development and treatment strategies, as well as TB biomarkers and diagnostics.
He is a U.S. Board certified Infectious Diseases specialist. He received his bachelors degree in Public Health from the Johns Hopkins University, and his medical degree from the University of Maryland School of Medicine. From there he went on to complete his training in Internal Medicine and Infectious Diseases at the Washington Hospital Center, Georgetown University, in Washington, D.C..